Results 241 to 250 of about 366,889 (322)

Protocol for an Integrative Meta‐Analysis of the Application of Machine Learning Algorithms in the Prediction of Chronic Disease Risks and Outcomes

Chronic Diseases and Translational Medicine, EarlyView.
ABSTRACT Background Precise risk prediction of chronic diseases is essential for effective preventive care and management. Machine learning (ML) is a promising avenue to enhance chronic disease risk prediction; however, a comprehensive assessment of ML performance across various chronic diseases, populations, and health settings is needed. Methods This
Ebenezer Afrifa‐Yamoah, Emmanuel Peprah‐Yamoah, Enoch Odame Anto, Victor Opoku‐Yamoah, Eric Adua   +4 more
wiley   +1 more source

Public Attitudes Toward Violence Against Doctors: Sentiment Analysis of Chinese Users.

JMIR Med Inform
Zheng Y, Tian M, Chen J, Zhang L, Gao J, Li X, Wen J, Qu X.   +7 more
europepmc   +1 more source

Correction: A lexicon-based diachronic comparison of emotions and sentiments in literary translation: A case study of five Chinese versions of David Copperfield. [PDF]

PLoS One
Li Y, Afzaal M, Yin Y.
europepmc   +1 more source

ESG Messaging on Social Media and Cost of Capital: A Canadian Perspective

Canadian Journal of Administrative Sciences / Revue Canadienne des Sciences de l'Administration, EarlyView.
ABSTRACT We examine whether environmental, social and governance (ESG) communications on social media decrease firms' cost of equity. Our results show that ESG messaging on social media does not appear to influence investors, which leads us to examine why.
Dhruv Baswal, Sean Cleary
wiley   +1 more source

3DZSignDB: 3D avatar SigML data for Algerian sign language. [PDF]

Data Brief
Zerrouki T, Slimani MF, Mami A, Mazari R.   +3 more
europepmc   +1 more source

Clinically Important Endpoints in Individuals With Leukodystrophy: A Multisite Study

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Importance Leukodystrophies are a diverse group of rare disorders that disrupt central myelination. These disorders present with a broad spectrum of neurological severity and are associated with a range of potential secondary complications, such as scoliosis and failure of independent feeding.
Emma R. Kotes, Sarah Woidill, Russell D'Aiello, Amina Khan, Jacob McCann, Mark Ramos, Francesco Gavazzi, Stephanie Keller, Keith Van Haren, Ali Fatemi, Florian Eichler, Joshua Bonkowsky, Jamie Fraser, Lisa Emrick, Omar Sherbini, Ashley Hackett, Jeilo Gauna, Dandre Amos, Jordan Goodman, Amena Smith Fine, Amanda Nagy, Seungil Lee, Nicole Page, Johanna Schmidt, Amy Pizzino, Kayla Muirhead, Mariko Bennett, Amy Waldman, Justine Shults, Laura Adang, Robert Grundmeier, Adeline Vanderver   +31 more
wiley   +1 more source

Diabetes and pregnancy: The need for standardized terminology. [PDF]

Obstet Med
Gonzales-Valdivieso R, Fuentes-Mendoza JM, Coronado-Arroyo JC, Acho-Carranza EA, Concepción-Zavaleta M.   +4 more
europepmc   +1 more source

Pharmacokinetics and Safety Evaluation of a New Generic Sitafloxacin: A Phase I Bioequivalence Study in Healthy Chinese Participants

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Sitafloxacin is a new antibiotic drug belonging to the fourth generation quinolone antibiotics. The aim of this study was to evaluate the pharmacokinetics (PK), safety profiles, and bioequivalence of test and reference 50‐mg sitafloxacin tablets under fasting and fed conditions.
Yongfang Lei, Pan Luo, Yuzhu Chen, Liuliang Xue, Donglin Zhang, Xingxing Qi, Yinian Fang, Hengyi Yu, Zheng He, Qin Zuo, Chang Liu, Dong Liu, Xinhua Ren, Qian Chen   +13 more
wiley   +1 more source

Evaluation of Potential Effects of CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Fruquintinib in Healthy Subjects

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Cytochrome P450 (CYP) 3A plays a significant role in fruquintinib metabolism in vitro. This 2‐part, 2‐period fixed‐sequence study investigated the impact of CYP3A inhibition (itraconazole) and CYP3A induction (rifampin) on the pharmacokinetics (PK) of fruquintinib and M11, its main metabolite.
Martha Gonzalez, Zhao Yang, William R Schelman, Xiaofei Zhou, Neeraj Gupta, Caly Chien   +5 more
wiley   +1 more source